Bifunctional protein-polymer bioconjugates for localized melanoma immunotherapy
Ended Project Grant Awarded Last action
- Award ID
- R43CA233108
- Recipient
-
Valitor, Inc. UEI MAUBKJ5FZ2K5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $297,813
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Berkeley, CA 94710, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | -$350 | |
| Amendment | -$350 | |
| Amendment | -$350 | |
| Amendment | $0 | |
| Original award | $298,864 |
Quick answers
Who received award R43CA233108?
R43CA233108 was awarded to Valitor, Inc. by National Cancer Institute (National Institutes of Health) on September 13, 2018.
How much is award R43CA233108 worth?
$297,813 has been obligated on R43CA233108.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award